Part B - GENERAL PROVISIONS RESPECTING NATIONAL RESEARCH INSTITUTES
- Section 284 - Directors of national research institutes
- Section 284a - Advisory councils
- Section 284b - Repealed
- Section 284c - Certain uses of funds
- Section 284d - Definitions
- Section 284e - Research on osteoporosis, Paget's disease, and related bone disorders
- Section 284f - Parkinson's disease
- Section 284g - Expansion, intensification, and coordination of activities of National Institutes of Health with respect to research on autism spectrum disorder
- Section 284h - Pediatric Research Initiative
- Section 284i - Autoimmune diseases
- Section 284j - Muscular dystrophy research
- Section 284k - Clinical research
- Section 284l - Enhancement awards
- Section 284m - Program for pediatric studies of drugs
- Section 284m-1 - Pediatric Advisory Committee
- Section 284n - Certain demonstration projects
- Section 284o - Activities of the National Institutes of Health with respect to research on paralysis
- Section 284p - Activities of the National Institutes of Health with respect to research with implications for enhancing daily function for persons with paralysis
- Section 284q - Pain research
- Section 284q-1 - NIH opioid research
- Section 284r - Basic research
- Section 284s - Tick-borne diseases